Interim Results Of Abbott’s PROGRESS Study Show Rapid Viral Decline In Dual-Therapy Regimen Of Kaletra(R) (lopinavir/ritonavir) And Raltegravir

May 13, 2009 by admin 

Interim results of Abbott’s PROGRESS study showed that Kaletra┬« combined with raltegravir suggested a more rapid initial viral load decline when compared to a traditional triple-drug combination therapy of Kaletra and Truvada┬«.

Source: Interim Results Of Abbott’s PROGRESS Study Show Rapid Viral Decline In Dual-Therapy Regimen Of Kaletra(R) (lopinavir/ritonavir) And Raltegravir

Comments

Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!





Security Code: